Seasoned healthcare and growth-stage investor with experience in private equity, venture and portfolio company operating roles.
Matthew Ottusch is a senior investor and board director who has led deal sourcing, due diligence, growth initiatives, and exits across healthcare services and healthtech.
Focuses on value creation through commercial scale-up, strategic M&A and operational improvements; engages with LPs on fundraising and portfolio governance.
Seasoned healthcare and growth-stage investor with experience in private equity, venture and portfolio company operating roles.
Matthew Ottusch is a senior investor and board director who has led deal sourcing, due diligence, growth initiatives, and exits across healthcare services and healthtech.
Focuses on value creation through commercial scale-up, strategic M&A and operational improvements; engages with LPs on fundraising and portfolio governance.
Invests primarily in growth-stage healthcare services and healthtech, applying a value-oriented growth lens that emphasizes commercial scale-up, strategic M&A and operational transformation. Allocates capital toward companies with durable clinical economics and scalable go-to-market models, favoring board-level engagement and staged commitments tied to KPI-driven milestones. Time horizon is multi-year with active governance to de-risk execution; underwriting centers on revenue unit economics, management depth, clear exit pathways and repeatable integration playbooks.
Invests primarily in growth-stage healthcare services and healthtech, applying a value-oriented growth lens that emphasizes commercial scale-up, strategic M&A and operational transformation. Allocates capital toward companies with durable clinical economics and scalable go-to-market models, favoring board-level engagement and staged commitments tied to KPI-driven milestones. Time horizon is multi-year with active governance to de-risk execution; underwriting centers on revenue unit economics, management depth, clear exit pathways and repeatable integration playbooks.
| Trades 567 | Longs Won 387/567 68% | Profit Factor 7.39 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $159,399.32 |
| Average Win $76,201.65 | Best Trade (Aug 14) $1.44M | Sharpe Ratio -12.14 |
| Average Loss -$22,167.14 | Worst Trade (Aug 02) -$593,496.96 | Z-Score 9.1 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w 3d | Expectancy $45,526.19 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,757 | 6,081 | 5,405 | 4,730 | 4,054 | 3,378 | 2,703 | 2,027 | 1,351 | 676 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 7840 78409V112 | 1,125 | $458,240 | $458,240 | - | - | - | 0.0 |
AAPL Apple Inc. | 6,227 | $1.55M | $1.92M | - | $374,529.37 | 24.18% | -7.354% |
ABT Abbott Laboratories | 2,698 | $357,889.83 | $285,178.6 | - | -$72,711.23 | -20.32% | +0.085% |
ACIO Aptus Collared Investment Opportunity ETF | 313,908 | $12.75M | $14.42M | - | $1.67M | 13.1% | +0.635% |
ACN Accenture plc Class A | 2,939 | $708,619.95 | $487,638.88 | - | -$220,981.07 | -31.18% | +1.611% |
ADI Analog Devices, Inc. | 1,221 | $388,448.8 | $448,607.61 | - | $60,158.81 | 15.49% | +0.202% |
ADME Aptus Drawdown Managed Equity Fund | 35,977 | $1.72M | $1.98M | - | $263,963.09 | 15.34% | +0.629% |
ADP Automatic Data Processing Inc. | 2,768 | $749,225.18 | $737,561.25 | - | -$11,663.93 | -1.56% | +0.982% |
AFL Aflac Inc. | 4,961 | $519,898.34 | $632,428.28 | - | $112,529.94 | 21.64% | +0.094% |
AMZN Amazon.com Inc | 945 | $225,288 | $256,643.09 | - | $31,355.09 | 13.92% | +15.321% |
AVGO Broadcom Inc. | 1,749 | $546,475.4 | $680,850.72 | - | $134,375.32 | 24.59% | +0.371% |
AVNV Avantis All International Markets Value ETF | 4,658 | $365,327 | $386,763.05 | - | $21,436.05 | 5.87% | -0.608% |
AVUV Avantis U.S. Small Cap Value ETF | 2,865 | $269,660.16 | $358,927.2 | - | $89,267.04 | 33.1% | +0.032% |
BLK BlackRock, Inc. | 356 | $342,108.84 | $388,178.84 | - | $46,070 | 13.47% | -0.727% |
BOXX Alpha Architect 1-3 Month Boxx Fund | 3,738 | $437,682 | $439,962.6 | - | $2,280.6 | 0.52% | +0.06% |
BRK-A Berkshire Hathaway Inc. | 1 | $680,920 | $766,600 | - | $85,680 | 12.58% | +0.21% |
BTC Grayscale Bitcoin Mini Trust ETF | 106,264 | $3.27M | $2.96M | - | -$311,219.67 | -9.53% | -2.864% |
CALF Pacer US Small Cap Cash Cows 100 ETF | 25,898 | $1.13M | $1.4M | - | $274,295.73 | 24.28% | -0.404% |
CAT Caterpillar Inc. | 449 | $176,145.76 | $365,849.69 | - | $189,703.93 | 107.7% | +0.701% |
CB Chubb Limited | 1,480 | $417,742.69 | $519,006.39 | - | $101,263.7 | 24.24% | +0.151% |